Accusure Insulin Syringe Recall: Needles May Detach from Syringe

The FDA issued a MedWatch safety alert on Tuesday to notify healthcare professionals and patients about a massive insulin syringe recall involving 250 million Accusure insulin syringes manufactured by Qualitest Pharmaceuticals, which could have defective needles that detach from the syringe.

The Accusure Insulin Syringe recall involves all syringes distributed between January 2002 and October 2009 to wholesale and retail pharmacies throughout the United States. Although no injuries have been reported, problems with the syringes could cause needles to remain stuck in the skin after an injection, push back into the syringe or become stuck in the insulin vial.

A prior recall for Accusure Insulin Syringes was issued in August for only two lots. However, according to an Associated Press report, Qualitest officials expanded the recall to include all Accusure syringes after receiving learning of a needle detaching from a syringe that was not included in the in the first two lots.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall now includes syringes with the following descriptions and NDC numbers:

  • 28G 1/2cc, NDC 0603-6995-21
  • 28G 1cc, NDC 0603-6996-21
  • 29G 1/2cc NDC 0603-6997-21
  • 29G 1cc, NDC 0603-6998-21
  • 30G 1/2cc, NDC 0603-999-21
  • 30G 1cc, NDC 0603-7000-21
  • 31G 1/2cc, NDC 0603-7001-21
  • 31G 1cc, NDC 0603-7002-21

Consumers who have any recalled Accusure insulin syringes should contact the company at 1-800-444-4011 for more information. Anyone who has experienced an adverse reaction due to these defective insulin syringes should report the incident to the FDA’s MedWatch program at http://www.fda.gov/medwatch/report.htm. If serious injuries were caused by the syringe needle detaching in the skin, product liability lawyers recommend that the defective syringe be preserved until after it has been determined whether a lawsuit will be pursued.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges
Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges (Posted 2 days ago)

A Kentucky man's lawsuit claims Ozempic and Rybelsus side effects led to multiple trips to the emergency room due to nausea, vomiting and other reactions to his intestinal muscles being unable to push food through his digestive tract.

Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures
Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures (Posted 2 days ago)

Lawyers will be meeting with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, 2024, to finalize information needed to select a group of representative cases for bellwether discovery and trial.

Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure
Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure (Posted 3 days ago)

Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.